Skip to main content
. 2021 Mar 13;13(6):1279. doi: 10.3390/cancers13061279

Table 4.

Adverse events according to NCI CTCAE v.4.0.

Adverse Event Grade 1–2
n/N (%)
Grade 3
n/N (%)
N.a.
n/N (%)
Anemia 71/105 (68) 1/105 (1) 6/105 (6)
Leucopenia 44/105 (42) 1/105 (1) 6/105 (6)
Neutropenia 6/105 (6) - 6/105 (6)
Neutropenic fever - 1/105 (1) 6/105 (6)
Thrombocytopenia 38/105 (36) - 6/105 (6)
Elevated creatinine 15/105 (14) - 6/105 (6)
Elevated bilirubine 12/105 (11) - 6/105 (6)
Elevated transaminases (AST/ALT) 41/105 (39) 2/105 (2) 6/105 (6)
Elevated alkaline phosphatase 19/105 (18) - 6/105 (6)
Aconuresis 4/105 (4) - 7/105 (7)
Allergic reaction 11/105 (10) 2/105 (2) 7/105 (7)
Alopecia 5/105 (5) - 7/105 (7)
Anal incontinence 29/105 (28) 1/105 (1) 7/105 (7)
Diarrhea 74/105 (70) 10/105 (10) 7/105 (7)
Dyspnea 9/105 (9) - 7/105 (7)
Emesis 15/105 (14) - 7/105 (7)
Erectile dysfunction 9/82 (11) 1/82 (1) 5/82 (6)
Fatigue 67/105 (64) - 7/105 (7)
Fever 15/105 (14) - 7/105 (7)
Hand-foot-syndrome 7/105 (7) - 7/105 (7)
Heart disorder 5/105 (5) - 7/105 (7)
Hemorrhage 50/105 (48) 1/105 (1) 7/105 (7)
Mucositis 18/105 (17) 1/105 (1) 7/105 (7)
Nausea 39/105 (37) 2/105 (2) 7/105 (7)
Non-infectious cystitis 53/105 (50) 2/105 (2) 7/105 (7)
Obstipation 39/105 (37) - 7/105 (7)
Pain 56/105 (53) 4/105 (4) 7/105 (7)
Peripheral motoric neuropathy 8/105 (8) - 7/105 (7)
Peripheral sensoric neuropathy 64/105 (61) - 7/105 (7)
Proctitis 62/105 (59) 3/105 (3) 7/105 (7)
Radiodermatitis 71/105 (68) 7/105 (7) 7/105 (7)
Urge to urinate 40/105 (38) - 7/105 (7)
Vaginal stenosis 3/23 (13) - -
Weight loss 23/105 (22) - 7/105 (7)
Other non-hematological AEs 20/105 (19) 7/105 (7) 6/105 (6)

N.a.: not available. AEs: adverse events. AST: glutamyl oxaloacetic transaminase/aspartate aminotransferase; ALT: glutamyl pyruvic transaminase/alanine aminotransferase.